Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 721–740 of 17,529 recalls

March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Saxagliptin Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets 150mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules 325mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Voriconazole Tablets 50mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Colesvelam Hydrocholoride Tablets 625mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Saxagliptin Tablets 5mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Nitroglycerin Sublingual Tablets 0.4MG 100-count carton

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Acetaminophen and Ibuprofen (NSAID) Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules USP

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rufinamide Tablets 200mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets 80mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets 200mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fluphenazine Hydrochloride Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rosuvastatin Tablets 40mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Indomethacin Extended-Release Capsules

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund